Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ejlertsen

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancerC Kamby, J Andersen, B Ejlertsen, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve functionS H Sindrup, B Ejlertsen, A Frøland, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Body size and menopausal status in relation to the pattern of spread in recurrent breast cancerC Kamby, B Ejlertsen, J Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
The pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survivalC Kamby, B Ejlertsen, J Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized studyB Kristensen, B Ejlertsen, P Dalgaard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 monthsB Ejlertsen, P Pfeiffer, D Pedersen, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Stage and pattern of metastases in patients with breast cancerC Kamby, C Rose, B Ejlertsen, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Adjuvant systemic treatment and the pattern of recurrences in patients with breast cancerC Kamby, C Rose, B Ejlertsen, et al.
Genes, Chromosomes & Cancer|September 18, 1997
Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in situ hybridizationK V Nielsen, E Niebuhr, B Ejlertsen, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative GroupB Ejlertsen, I Højris, S Hansen, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancerC Kamby, J Andersen, B Ejlertsen, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve functionS H Sindrup, B Ejlertsen, A Frøland, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Body size and menopausal status in relation to the pattern of spread in recurrent breast cancerC Kamby, B Ejlertsen, J Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
The pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survivalC Kamby, B Ejlertsen, J Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized studyB Kristensen, B Ejlertsen, P Dalgaard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 monthsB Ejlertsen, P Pfeiffer, D Pedersen, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Stage and pattern of metastases in patients with breast cancerC Kamby, C Rose, B Ejlertsen, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Adjuvant systemic treatment and the pattern of recurrences in patients with breast cancerC Kamby, C Rose, B Ejlertsen, et al.
Genes, Chromosomes & Cancer|September 18, 1997
Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in situ hybridizationK V Nielsen, E Niebuhr, B Ejlertsen, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative GroupB Ejlertsen, I Højris, S Hansen, et al.
Pageof 4